hb electrophoresis test price lal path lab
139080. 105952922.95999999. Med slagordet Tech is Back lover den tyske forbrugerelektronikkmessen, at IFA 2021 vil finne sted mellom 3. og 7. september 2021. To mennesker gjør en hel natt det ytterste for å såre, og fornedre, sin partner. 7472075.7800000003. 18965.36. Tast inn din e-post og du vil motta en link hvor du kan lage nytt passord. 101952.25. Og i fremtiden kan den oppgraderes i stedet for å bli kastet. Gigantenes reklamekrig er allerede i full gang. Jern har gitt konseptet en ansiktsløfting, og det har resultert i en enda bedre høyttaler. Xiaomi Mi 11 var den første smarttelefonen med Qualcomms nye Snapdragon 888 prosessor. View details of any pathology test such as type of test, pre-test information, report availability and price. Audi e-tron GT og Audi RS e-tron GT kan bestilles fra 18. februar. Kinesiske Xiaomi vil markere seg i TV-markedet med en ny 75" Android-TV. Det er ingen reell forskjell på Huaweis "nye" mobile operativsystem og Android. Seriøs forsterker for high-end hodetelefoner. substancial - Free ebook download as Text File (.txt), PDF File (.pdf) or read book online for free. 168624. 0. Vi har lyttet til toppmodellen. De leverer prisvarsling, produktinformasjon og oppdaterte priser. © 2020 Publish AS - Lyd & Bilde arbeider etter Vær Varsom-plakatens regler for god presseskikk. På jakt etter en elegant TV som tar liten plass? For X-Ray, Ultrasound, ECG, TMT, Echo, PFT, Uroflowmetry reports please visit the concerned center where test has been conducted. Billingstadsletta 19 B 10868.97. Publish AS 49 Likes, 1 Comments - College of Medicine & Science (@mayocliniccollege) on Instagram: “ Our Ph.D. Men det er en kraftfull sak, så det er avgjørende for resultatet at man behandler og stiller den rett inn. Sjekk videoen her! A-Z list of medical tests from Dr Lal PathLabs. Det kan føre til dårlig kroppsholdning, smerter, og generelt gå ut over trivselen. Artikler som ligger utenfor plusstjenesten er ≪kjøpt fri≫ av muren av vedkommende produsent/leverandør. Slikt blir det filmkunst av. I have been a nurse since 1997. For tutoring please call 856.777.0840 I am a recently retired registered nurse who helps nursing students pass their NCLEX. As a student,…” Sterke kvinner, med sine høyst personlige problemer, er den drivende kraften i dette sterke Netflix-dramaet. 1396 Billingstad Question Completion Status Take Test pH Lab Activity QUES L A Moving to the next question prevents changes to this a The standard direct labor cost per unit for a company was 2 17 In the video Balanced Scorecard Southwest Airlines a Q1 Assume that you are working as a mechanical engineer in True or False a ___ When all identifying assumptions are v 9275.44. Use the following coupon code : ESYD15%2020/21 Copy without space Altasciences 1140 Avenue Beaumont Clinic Mont-Royal, QC, H3P 3E5 Canada Visit our YouTube Channel "Altasciences". Glem de billigere mesh-løsningene. 49971. NB! Du kan ikke bruke Innhold, herunder (men ikke begrenset til) ikoner, for noen andre formål eller på noen andre måter enn de som er uttrykkelig tillatt. Bang & Olufsens nye trådløse høyttaler tilpasser seg omgivelsene. We would like to show you a description here but the site won’t allow us. Only Pathology reports available online. Med slagordet Tech is Back lover den tyske forbrugerelektronikkmessen, at IFA 2021 vil finne sted mellom 3. og 7. september 2021. Med fem enkle steg kan man imidlertid både få det bedre, forbedre ergonomien og skape en mer effektiv arbeidsdag. All Right Reserved. Pro-Ject har oppgradert retrospilleren The Classic, og skapt et av de beste kjøpene i klassen. 3145.28. Du kan få AIAIAIs hodetelefoner akkurat som du vil ha dem – for du kombinerer delene selv. Get a 15% discount on an order above $ 120 now. 17 - HYDROXY- CORTICOSTEROIDS & 17 - KETOSTEROIDS, 24 HOUR URINE, 17 - HYDROXY- CORTICOSTEROIDS (17-OHCS), 24 HOUR URINE, 17-HYDROXYPROGESTERONE (17–OHP) STIMULATION BY ACTH, 17 - HYDROXYPROGESTERONE NEWBORN SCREEN; CAH SCREEN, 5-AMINOLEVULINIC ACID (5 -ALA), 24 HOUR URINE, 5-HIAA (5-HYDROXY INDOLE ACETIC ACID), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5 -ALA), RANDOM URINE, 5 - HIAA (5-HYDROXY INDOLE ACETIC ACID), RANDOM URINE, ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP, ANTI - ds DNA ANTIBODY CRITHIDIA, IFA IN DILUTIONS, ACETYLCHOLINE RECEPTOR (ACHR) BLOCKING ANTIBODY, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), SERUM, ACETYLCHOLINE RECEPTOR (ACHR) MODULATING ANTIBODY, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), CSF, ANCA (ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES) POSITIVE REFLEX TO ANCA- MPO & ANCA-PR3, ACETYLCHOLINE RECEPTOR (ACHR) BINDING ANTIBODY, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, CSF, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, SERUM, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, SERUM, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, CSF, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) REFLEX TO ENA PROFILE, ACUTE LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE, ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CYTOGENETICS PANEL, ACUTE MYELOID LEUKEMIA (AML) CYTOGENETICS PANEL, ADDON-SARS COV-2 (COVID-19) TOTAL ANTIBODIES, SERUM, ANTI THYROID PEROXIDASE ANTIBODY; ANTI TPO, ADENOVIRUS ANTIGEN FOR GASTROENTERITIS, STOOL, ADENOVIRUS ANTIGEN FOR RESPIRATORY INFECTIONS, ADRB2 GENOTYPING FOR BETA-2 AGONIST RESPONSIVENESS, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) PANEL IgA & IgG, ALCOHOL ETHYL GLUCURONIDE (EtG) & ETHYL SULPHATE (EtS) QUANTITATIVE ASSAY, URINE, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgG, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) PANEL, ALLERGY ASTHMA / RHINITIS SCREENING PANEL ADULT, ALLERGY ECZEMA SCREENING PANEL, PEDIATRIC, ALLERGY WHEEZE / RHINITIS SCREENING PANEL PEDIATRIC, ALDOSTERONE / RENIN DIRECT RATIO, PLASMA, ALKALINE PHOSPHATASE, BONE-SPECIFIC; BSAP, ALLERGY ECZEMA PANEL FOR NON-VEGETARIANS, ALKALINE PHOSPHATASE BONE-SPECIFIC; BSAP, ALLERGY FOOD SCREENING PANEL FOR INDIAN POPULATION, AMINO ACID NON-KETOTIC HYPERGLYCINEMIA PANEL QUANTITATIVE, CSF & PLASMA, AMINO ACID QUANTITATIVE CSF: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS MAPLE SYRUP URINE DISEASE (MSUD) PANEL, PLASMA, ALLERGY BERMUDA GRASS (Cynodon dactylon / Doob), ALLERGY INHALATION SCREENING PANEL FOR INDIAN POPULATION, AMINO ACIDS QUALITATIVE ONE DIMENSIONAL, URINE, AMINO ACIDS QUALITATIVE TWO DIMENSIONAL, URINE, AMINO ACIDS QUANTITATIVE BLOOD: 10 AMINO ACIDS, AMINO ACIDS QUANTITATIVE PLASMA: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE URINE: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE, URINE & PLASMA: 45 AMINO ACIDS / FULL PANEL, AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, ALLERGY WHEEZE / RHINITIS COMPREHENSIVE PANEL ADULT, AML ETO t(8;21) GENE REARRANGEMENT PCR QUALITATIVE, ALLERGY WHEEZE / RHINITIS COMPREHENSIVE PANEL PEDIATRIC, ALLERGY PEDIATRIC FOOD & INHALATION SCREENING PANEL FOR INDIAN POPULATION, ALLERGY COMMON PIGWEED (Kantewali Chauli), ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), EIA, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) END POINT TITRE, ANCA (ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES) EXTENDED PROFILE IgG, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA IN DILUTIONS, ANCA-MPO (ANTI MYELOPEROXIDASE ANTIBODIES), EIA, ANCA-PR3 (SERIN PROTEINASE 3 ANTIBODIES), EIA, AUTOIMMUNE BULLOUS DERMATOSES PROFILE IgG, ALLERGY JOHNSON GRASS (Sorghum halepense / Jowar), AUTO IMMUNE ENCEPHALITIS PANEL, SERUM & CSF, AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL, ASPERGILLUS ANTIBODIES PANEL IgG & IgM, SERUM, ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2), ALLERGY MUG WORT (Artemisia vulgaris / Barna), Anti-NMO (NEUROMYELITIS OPTICA ) ANTIBODY / AQUAPORIN 4, BOH (BAD OBSTETRIC HISTORY) ADVANCED PANEL, BOH (BAD OBSTETRIC HISTORY) EXTENDED PANEL, BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE I C-TELOPEPTIDE, BIOFIRE GI (GASTROINTESTINAL) PANEL, STOOL, BIOFIRE ME (MENINGOENCEPHALITIS) ADVANTAGE, BIOFIRE ME (MENINGOENCEPHALITIS) PANEL, CSF, BIOTINIDASE ACTIVITY QUANTITATIVE, BLOOD, BRCA1 & BRCA2 MUTATION COMPREHENSIVE PANEL, BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL, BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE, BCR-ABL GENE REARRANGEMENT PCR QUANTITATIVE, BENZODIAZEPINE SCREEN QUALITATIVE, URINE, BETA 2 GLYCOPROTEIN 1 PANEL IgG, IgM & IgA, BLOOD GLUCOSE R + CHOLESTEROL TOTAL+ HB% + TSH, BETA CTx; BETA CROSSLAPS; COLLAGEN TYPE 1C-TELOPEPTIDE, BUCCAL SMEAR FOR BARR BODIES (SEX CHROMATIN), BLOOD PICTURE; PERIPHERAL BLOOD SMEAR EXAMINATION, C1 ESTERASE INHIBITOR FUNCTIONAL; C1 INACTIVATOR FUNCTIONAL, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 DRUGS PANEL, C1 ESTERASE INHIBITOR PROTEIN QUANTITATION; C1 INHIBITOR QUANTITATIVE, CULTURED AFB ANTITUBERCULAR DST, RAPID 11 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 12 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 4 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 DRUGS PANEL, CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY, CULTURED AFB ANTITUBERCULAR DST, AMIKACIN, CHROMOSOME ANALYSIS, PRODUCTS OF CONCEPTION REFLEX TESTING TO FISH FOR ANEUPLOIDY DETECTION, CULTURED AFB ANTITUBERCULAR DST, CAPREOMYCIN, CHROMOSOME ANALYSIS HIGH RESOLUTION, NEONATAL, CULTURED AFB ANTITUBERCULAR DST, CLOFAZIMINE, CULTURED AFB ANTITUBERCULAR DST, CYCLOSERINE, CHROMOSOME ANALYSIS (KARYOTYPE) COUPLE, BLOOD, CULTURED AFB ANTITUBERCULAR DST, ETHAMBUTOL, CULTURED AFB ANTITUBERCULAR DST, ETHIONAMIDE, CULTURED AFB ANTITUBERCULAR DST, ISONIAZID, CHROMOSOME INTERPHASE PROFILING, AMNIOTIC FLUID, CULTURED AFB ANTITUBERCULAR DST, KANAMYCIN, CHROMOSOME INTERPHASE PROFILING, PRODUCTS OF CONCEPTION, CULTURED AFB ANTITUBERCULAR DST, LEVOFLOXACIN, CHROMOFIC CHROMOSOME SNP MICROARRAY 750K, HIGH RESOLUTION, CULTURED AFB ANTITUBERCULAR DST, MOXIFLOXACIN, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRENATAL, CA 27.29 & CA 15.3; BREAST CANCER MARKERS PANEL, CULTURED AFB ANTITUBERCULAR DST, OFLOXACIN, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRODUCTS OF CONCEPTION, CHROMOSOME XON MICROARRAY, HIGH RESOLUTION, CULTURED AFB ANTITUBERCULAR DST, PYRAZINAMIDE, CHROMULTRA CHROMOSOME SNP HD MICROARRAY, CULTURED AFB ANTITUBERCULAR DST, RIFAMPICIN, CULTURED AFB ANTITUBERCULAR DST, STREPTOMYCIN, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), PROGNOSTIC PANEL, CALCITONIN STIMULATION BY CALCIUM - PENTAGASTRIN, CULTURED ANAEROBIC BACTERIA IDENTIFICATION, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION COMPREHENSIVE PANEL, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION PANEL 1, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION PANEL 2, CULTURED MOLD ANTIFUNGAL DRUG SENSITIVITY (DST) TEST, CULTURE ESBL (EXTENDED SPECTRUM BETA-LACTAMASE) SCREENING, CIRCULATING TUMOR CELLS (CTC) FOR BREAST CANCER, CIRCULATING TUMOR CELLS (CTC) FOR COLORECTAL CANCER, CULTURE, FUNGUS, BLOOD / BODY FLUIDS RAPID, CIRCULATING TUMOR CELLS (CTC) FOR PROSTATE CANCER, CKD (CHRONIC KIDNEY DISEASE) MANAGEMENT PANEL, CULTURE MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS) SCREENING, CULTURE, MYCOBACTERIUM ATYPICAL(NON TUBERCULOUS MYCOBACTERIUM-NTM), CANCER TARGETED GENE PANEL: COLON / COLORECTAL, CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST), CULTURE WATER: PRESUMPTIVE COLIFORM COUNT, CANCER TARGETED GENE PANEL : LUNG WITH PDL-1 (DAKO), CYTOMEGALOVIRUS (CMV) ANTIBODIES PANEL, IgG & IgM, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA CONFIRMATION, URINE, CYTOMEGALOVIRUS (CMV) DNA, QUANTITATIVE PCR, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA SCREEN, URINE, CYSTICERCOSIS (TAENIA SOLIUM) ANTIBODY, IgG, CARDIOLIPIN ANTIBODIES PANEL IgG, IgA & IgM, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, CONVENTIONAL, COCAINE AND METABOLITE CONFIRMATION, URINE, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, LIQUID BASED, COLLAGEN CROSS-LINKED N-TELOPEPTIDE (NTx), RANDOM URINE, CYTOMEGALOVIRUS, INTERFERON GAMMA RELEASE ASSAY (IGRA), CATECHOLAMINES FRACTIONATED, 24-HOUR URINE, COMPLETE BLOOD COUNT ADVANCED; CBC ADVANCED, CATECHOLAMINES FRACTIONATED, RANDOM URINE, CORTISOL SERUM: MORNING & EVENING SAMPLES, CONGENITAL HYPOTHYROIDISM CONFIRMATORY PANEL, SERUM, CULTURE AEROBIC BRONCHOALVEOLAR LAVAGE (BAL), CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT HIGH DOSE, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE, CULTURE AEROBIC ENDOTRACHEAL (ET) SECRETIONS, CULTURE AEROBIC MISCELLANEOUS WITH GRAM STAIN, CULTURE AFB (MYCOBACTERIUM) RAPID WITH PNB TEST, CHIMERISM PRE-ENGRAFTMENT DONOR & RECIPIENT, CHIMERISM SPLIT CELL ANALYSIS - MYELOID CELL (CD15), CHIMERISM SPLIT CELL ANALYSIS - T Cell (CD3), CULTURE, BRUCELLA*DOES NOT INCLUDE ANTIBIOTIC SENSITIVITY*, CHIMERISM SPLIT CELL ANALYSIS - B CELL (CD19), CULTURED AEROBIC BACTERIA IDENTIFICATION, CULTURED AEROBIC BACTERIA IDENTIFICATION AND SENSITIVITY, CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE, CULTURED AFB ANTITUBERCULAR DST, RAPID 16 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, LINEZOLID, CULTURED AFB DRUG RESISTANT (DR MYCOBACTERIUM) ANTI-TUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR RAPID GROWERS, CRYPTOSPORIDIUM / ISOSPORA IDENTIFICATION, STOOL, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR SLOW GROWERS, CULTURED AFB ANTITUBERCULAR DST, RAPID 19 DRUGS PANEL, CSF LEAKAGE EVALUATION (NASAL/EAR DISCHARGE), CULTURED AFB ANTITUBERCULAR DST, CLARITHROMYCIN, CULTURED AFB ANTITUBERCULAR DST, RIFABUTIN, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 SECOND LINE DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 SECOND LINE DRUGS PANEL, DPYD (DEOXYPYRIDINOLINE) CROSSLINKS, URINE, DRPLA (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY) GENE ANALYSIS, DES-GAMMA CARBOXY PROTHROMBIN (DCP)/PIVKA II, SERUM, Dialysis SARS-COV-2 (COVID-19) SCREENING PROFILE, DUCHENNE / BECKER MUSCULAR DYSTROPHY (DMD / BMD) GENE MUTATION, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) PROFILE, DEEP VEIN THROMBOSIS PANEL; DVT PANEL, DHEA SULPHATE; DEHYDROEPIANDROSTERONE SULPHATE, DENGUE & CHIKUNGUNYA VIRUSES, PCR QUALITATIVE, DIPHTHERIA-PERTUSSIS-TETANUS ANTIBODY PANEL IgG, DLC (DIFFERENTIAL LEUCOCYTE COUNT), AUTOMATED, DLC (DIFFERENTIAL LEUCOCYTE COUNT), FLUID, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE, EPSTEIN BARR VIRUS ANTIBODIES TO VIRAL CAPSID ANTIGEN (VCA), IgG & IgM, EPSTEIN-BARR VIRUS ANTIBODY TO EARLY ANTIGEN (D), IgG, ENDOMYSIAL ANTIBODY IgA, IFA IN DILUTIONS, EPSTEIN-BARR VIRUS ANTIBODY TO NUCLEAR ANTIGEN (EBNA), IgG, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgG, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUALITATIVE PROFILE, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgM, EPSTEIN BARR VIRUS (EBV), QUALITATIVE PCR, ECHINOCOCCUS DETECTION FOR SCOLICES IN HYDATID CYST FLUID, ENTEROHEMORRHAGIC E.COLI VEROTOXIN 1 & 2 ANTIGEN, ECHINOCOCCUS (HYDATID SEROLOGY) IgG, SERUM, EPIDERMAL (PEMPHIGUS) ANTIBODY, IFA IN DILUTIONS, EPISODIC ATAXIA COMPREHENSIVE PROFILE, HOTSPOT, EPSTEIN-BARR VIRUS EARLY RNA (EBER-ISH) IN-SITU-HYBRIDIZATION, EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR, FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION, FISH - 14q32.3 OR LSI IGH GENE BREAKAPART, FISH - PDGFR ALPHA (4q12) GENE REARRANGEMENT, FACTOR XIII (CLOT SOLUBILITY) FUNCTIONAL, QUALITATIVE, FISH - PDGFR BETA (5q33) GENE REARRANGEMENT, FISH - 22q DELETION OR LSI Di GEORGE / VCFS, FISH - PRENATAL COMPREHENSIVE SCREENING PANEL 1, FISH - PRENATAL SCREENING PANEL CHROMOSOMES 13,18, 21, X & Y, FISH - AMNIO ONE PROBE: TRISOMY 21 / DOWN SYNDROME, FISH - RARA (17q21) VARIANT TRANSLOCATION, FISH - AMNIO THREE PROBES: TRISOMY 18, X & Y, FISH - AMNIO TWO PROBES: TRISOMY 13 & 21, FISH - ANEUPLOIDY DETECTION, PRODUCTS OF CONCEPTION (POC) USING CHROMOSOMES 13, 18, 21, X & Y, FISH - BCR / ABL OR PHILADELPHIA TRANSLOCATION, FISH - SYNOVIAL SARCOMA (SS18 / SYT ) 18q11.2 GENE REARRANGEMENT, FSH & LH STIMULATION BY GONADOTROPIN RELEASING HORMONE (GnRH), FUNGUS EXAMINATION, ROUTINE: KOH CALCOFLUOR WHITE PREPARATION, FISH - EWING SARCOMA (EWS), 22q12 (EWSR1) REARRANGEMENT, FEBRILE AGGLUTININS PANEL Combined Brucella, Widal and Weil Felix tests panel, FISH - FOLLICULAR LYMPHOMA (IGH/BCL2) t(14;18), FLUID EXAMINATION, ROUTINE, BODY FLUIDS, FLUID EXAMINATION, ROUTINE, CSF/ NASAL FLUID, FISH - MDS Panel - CHROMOSOMES 5q, 7q, 8q & 20q, FISH - MICRODELETION DETECTION FOR WILLIAMS SYNDROME, FISH - MULTIPLE MYELOMA WITH POSITIVE SELECTION OF CD138 CELLS, FISH - Multiple Myeloma with CD138 positive selection cells ( 5 Probes), FISH - t(8;14) OR MYC/IGH FOR BURKITT & NON-HODGKIN LYMPHOMA, FRAGILE X TREMOR / ATAXIA SYNDROME (FXTAS), FIBRINOGEN DEGRADATION PRODUCTS (FDP), BLOOD, FISH - NSCLC (NON-SMALL CELL LUNG CANCER) ALK1 & ROS1, GAD-65 (GLUTAMIC ACID DECARBOXYLASE- 65), IgG, GALACTOMANNAN (ASPERGILLUS ANTIGEN), BRONCHOALVEOLAR LAVAGE, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IgG, GALACTOMANNAN (ASPERGILLUS ANTIGEN), SERUM, GFR (GLOMERULAR FILTRATION RATE), ESTIMATED, GALACTOSE -1-PHOSPHATE QUANTITATIVE, BLOOD, GALACTOSEMIA CLASSICAL (TRANSFERASE) QUANTITATIVE, BLOOD, GALACTOSEMIA (EPIMERASE) QUANTITATIVE, BLOOD, GLUCOSE CHALLENGE TEST (GCT); GLUCOSE 1 HOUR OBSTETRICAL, GALACTOSEMIA (GALT) GENE MUTATION DETECTION, GLUCOSE CHALLENGE TEST (GCT), PREGNANCY, 75g GLUCOSE, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY, 100g GLUCOSE, GLUCOSE TOLERANCE TEST (GTT), PREGNANCY, 75g GLUCOSE, GLUCOSE FASTING (F) AND POST MEAL (PP), 2 HOURS, GM2 GANGLIOSIDOSIS QUANTITATIVE, BLOOD; TAY SACHS & SANDHOFF DISEASE, GENETIC MAPPING FOR CARDIOVASCULAR DISORDERS, GENETIC MAPPING FOR GYNECOLOGICAL DISORDERS, GRAM STAIN FOR BACTERIAL VAGINOSIS (BV), VAGINAL SWAB, GLUCOSE POST PRANDIAL (PP) 2 HOURS POST MEAL, GENEXPERT ULTRA (NEXT GENERATION) MTB WITH RIFAMPICIN RESISTANCE, SEMI QUANTITATIVE PCR, GLIADIN DEAMIDATED ANTIBODIES PANEL, IgA & IgG, HCG BETA TOTAL QUANTITATIVE, TUMOR MARKER, H1N1 (SWINE FLU) QUALITATIVE REAL TIME PCR, HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE, HAINS MYCOBACTERIUM TUBERCULOSIS FIRST & SECOND LINE DRUG RESISTANCE PROFILE, HLA DSA (DONOR SPECIFIC IgG ANTIBODIES), CLASS I & II, HAINS MYCOBACTERIUM TUBERCULOSIS SECOND LINE DRUG RESISTANCE PROFILE, HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN, HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN, HAIR TRANSPLANT PANEL B WITH COVID ANTIBODIES, Hepatitis B Surface Antigen (Hbsag) Rapid Screening, HLA HYPERSENSITIVITY TO ABACAVIR (B*57:01), HEPATITIS B SURFACE ANTIGEN (HBsAg) CONFIRMATION, HLA HYPERSENSITIVITY TO ALLOPURINOL (B*58:01), HAM TEST; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING TEST, HEPATITIS B VIRAL DRUG RESISTANCE & GENOTYPING, HLA HYPERSENSITIVITY TO CARBAMAZEPINE & PHENYTOIN (B*15:02), HEPATITIS B VIRAL (HBV DNA) QUANTITATIVE ULTRA, HLA - NARCOLEPSY (DRB1*15, DQB1*06:02, DQA1*01:02), HEPATITIS B VIRUS GENOTYPING, DRUG RESISTANCE & QUANTITATIVE PCR, HLA - PANEL REACTIVE IgG ANTIBODIES (PRA), CLASS II QUANTITATIVE, HEPATITIS B VIRUS PCR QUALITATIVE; HBV DNA PCR QUALITATIVE, HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS I, QUANTITATIVE, HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) SCREEN, HBDH; ALPHA-HYDROXYBUTYRATE DEHYDROGENASE, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPEINT PANEL1, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPIENT PANEL1, HEPATITIS B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN, HEPATITIS C VIRAL RNA PCR QUALITATIVE; HCV RNA PCR QUALITATIVE, HEPATITIS B SURFACE ANTIGEN (HBsAg), QUANTITATIVE, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3, HEPATITIS B VIRAL DNA (HBV DNA) QUANTITATIVE REAL TIME PCR, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE ULTRA, HHH SYNDROME; HYPERORNITHINEMIA - HYPERAMMONEMIA - HOMOCITRULLINURIA SYNDROME, Hepatitis C Virus (HCV) Rapid Screening Test, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5, HISTO / CYTOPATHOLOGY / IMMUNOHISTOCHEMISTRY (IHC) PHOTOMICROGRAPH, HISTO/CYTOPATHOLOGY SLIDE(S) / BLOCK(S) ISSUE, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I IgG ANTIBODIES; DSA-SAB CLASS I, HISTO/CYTOPATHOLOGY, SLIDES (S) / BLOCKS (S) ISSUE, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS II IgG ANTIBODIES; DSA-SAB CLASS II, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 6 TO 10 SLIDES, HEPATITIS G VIRUS (HGV) RNA DETECTION PCR, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 11 TO 20 SLIDES, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, UPTO 5 SLIDES, HISTOPATHOLOGY SPECIAL STAIN: ACID FAST (Z N STAIN), HISTOPATHOLOGY SPECIAL STAIN: ALCIAN BLUE, HISTOPATHOLOGY BIOPSY: LARGE COMPLEX / CANCER SPECIMEN, HISTOPATHOLOGY SPECIAL STAIN: COPPER (RHODANINE), HISTOPATHOLOGY SPECIAL STAIN: FONTANA MASSON, HISTOPATHOLOGY SPECIAL STAIN: GOMORI’S METHENAMINE SILVER, HERPES SIMPLEX VIRUS (HSV) 1 ANTIBODIES PANEL IgG & IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: IRON (PERL’S STAIN), HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY PANEL, HERPES SIMPLEX VIRUS (HSV) 1+2 IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: MASSON TRICHROME, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) KIDNEY BIOPSY, HERPES SIMPLEX VIRUS (HSV) TYPE 1 & 2, PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: MUCICARMINE, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C3, HERPES SIMPLEX VIRUS (HSV) TYPE 2 PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: PERIODIC ACID SCHIFF (PAS), HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgA, HERPES SIMPLEX VIRUS (HSV) TYPE I PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: AMYLOID (CONGO RED), HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgG, HISTOPATHOLOGY SPECIAL STAIN: PHOSPHOTUNGSTIC ACID HEMATOXYLIN (PTAH), HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgM, HERPES VIRUS 6 (HHV-6) ANTIBODIES PANEL IgG & IgM, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C1q, HERPES SIMPLEX VIRUS (HSV) 1+2 ANTIBODIES PANEL IgG & IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: VAN GIESONS, HCG BETA TOTAL QUANTITATIVE, 24 HOUR URINE, HERPES SIMPLEX VIRUS (HSV) 2 ANTIBODIES PANEL IgG & IgM, SERUM, HCG BETA TOTAL QUANTITATIVE, RANDOM URINE, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE REAL TIME PCR, HUMAN HERPESVIRUS 6 (HHV6) QUALITATIVE PCR, HUMAN HERPES VIRUS 7 (HHV7) QUALITATIVE PCR, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3, CD4 / CD8 (IMMUNE DEFICIENCY PANEL 2) MARKERS, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 / CD4 (IMMUNE DEFICIENCY PANEL 4) MARKERS, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I & II IgG ANTIBODIES; DSA-SAB CLASS I & II, HELICOBACTER PYLORI ANTIBODIES PANEL, IgA & IgG, HELICOBACTER PYLORI ANTIGEN, RAPID STOOL TEST, HEMOCHROMATOSIS DETECTION HFE GENOTYPING, HYPOTHYROIDISM / HASHIMOTO'S DISEASE PANEL, HLA MIXED ANTIBODY SCREEN - PRA CLASS I, II & MICA, HLA - CELIAC DISEASE (DR-DQB1-DQA1 HAPLOTYPE ASSOCIATION INCLUDING DQ2,DQ8), HOMA-IR; INSULIN RESISTANCE INDEX C-PEPTIDE MODEL, HEPARIN INDUCED THROMBOCYTOPENIA (HIT) / ANTI PLATELET FACTOR 4-HEPARIN (PF4-H), IgG QUANTITATIVE, HLA DNA HIGH RESOLUTION TYPING- A, B, C, DR & DQ, HPV, CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA PCR PANEL QUALITATIVE, HPV (HUMAN PAPILLOMA VIRUS) DETECTION & GENOTYPING QUALITATIVE PCR, HLA DNA TYPING HIGH RESOLUTION BY NEXT GENERATION SEQUENCING (NGS), HLA DNA HIGH RESOLUTION TYPING - DQB1 LOCUS, HLA DONOR SPECIFIC IgG ANTIBODIES & PANEL REACTIVE ANTIBODIES SCREEN PROFILE, HLA DNA HIGH RESOLUTION TYPING - DRB1 LOCUS, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 10 ANTIGENS PCR, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 6 ANTIGENS LUMINEX, HLA DNA TYPING FOR KIDNEY / LIVER TRANSPLANT PCR, HEPATITIS B CORE ANTIBODY (Anti-HBc), IgM, HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE, HEPATITIS B CORE ANTIBODY (Anti-HBc), TOTAL, IMMUNOHISTOCHEMISTRY, AFP (ALPHA FETO PROTEIN), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE ANY 6 MARKERS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA - T, B or MYELOID, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION, INTERLEUKIN-2 RECEPTOR ALPHA CHAIN; IL-2R, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL- CLL/HCL/SLL BASIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL CUSTOMIZED ANY 10 MARKERS, INTERLEUKIN 28B rs12979860 & rs 8099917 GENOTYPING QUALITATIVE PCR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-PLASMA CELL DYSCRASIAS, INTERLEUKIN-6 (IL-6) SARS-COV-2 (COVID-19) ADVANCED PANEL, IMMUNOHISTOCHEMISTRY, HUMAN CHORIONIC GONADOTROPIN (HCG), INTERLEUKIN-6 (IL-6) SARS-COV-2 (COVID-19) BASIC PANEL, Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUALITATIVE PCR, IMMUNOHISTOCHEMISTRY, LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA / LYMPHOMA DIAGNOSTIC PANEL-CHRONIC LYMPHOPROLIFERATIVE DISORDERS, T & B CELL, IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE (MPO), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA MONITORING PANEL-HAIRY CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: OBSTETRIC PANEL, IMMUNOHISTOCHEMISTRY, NEUROFILAMENT POLYPEPTIDE, IMMUNOHISTOCHEMISTRY, NEURON SPECIFIC ENOLASE (NSE), IBD (INFLAMMATORY BOWEL DISEASE) SCREENING PANEL, IMMUNOHISTOCHEMISTRY, ISOCITRATE DEHYDROGENASE (IDH-1), IMMUNOHISTOCHEMISTRY, POLYOMA BK VIRUS (SV 40), IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR), IMMUNOHISTOCHEMISTRY, PROSTATE SPECIFIC ANTIGEN (PSA), IMMUNOHISTOCHEMISTRY, SERUM ASSOCIATED AMYLOID (SAA), INFLUENZA LIKE ILLNESS / ILI SARS-CoV-2 (COVID-19) PANEL, IMMUNOHISTOCHEMISTRY, CEA (CARCINOEMBRYONIC ANTIGEN), IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA, IMMUNOHISTOCHEMISTRY, HER-2 / ERBB2 (BREAST), IMMUNOHISTOCHEMISTRY, TTF-1 (THYROID TRANSCRIPTION FACTOR-1), IMMUNOHISTOCHEMISTRY, CHROMOGRANIN-A (CGA), IMMUNOHISTOCHEMISTRY, CYTOMEGALOVIRUS (CMV), IMMIGRATION / IMMUNIZATION CHECK PANEL, ADVANCED, IMMUNOHISTOCHEMISTRY, CYTOKERATIN- 19 (CK-19), IMMUNOHISTOCHEMISTRY, LUTEINIZING HORMONE (LH), IMMIGRATION / IMMUNIZATION CHECK PANEL BASIC, IMMUNOHISTOCHEMISTRY, CYTOKERATIN-20 (CK-20), IMMUNOHISTOCHEMISTRY, CYTOKERATIN- 7 (CK-7), IMMUNOHISTOCHEMISTRY, CYTOKERATIN (PANCYTOKERATIN), IMMUNOHISTOCHEMISTRY, LUNG NON-SMALL CELL CARCINOMA (NSCC) PANEL, IMMUNOHISTOCHEMISTRY, EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), IMMUNOHISTOCHEMISTRY, EPITHELIAL MEMBRANE ANTIGEN (EMA), IMUNOHISTOCHEMISTRY, MICROSATELLITE INSTABILITY PANEL, IMMUNOHISTOCHEMISTRY, FOLLICLE STIMULATING HORMONE (FSH), IMMUNOFIXATION ELECTROPHORESIS (IFE), 24 HOUR URINE, IMMUNOHISTOCHEMISTRY, GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP), IMMUNOHISTOCHEMISTRY, GROWTH HORMONE (GH), IMMUNOHISTOCHEMISTRY, HEPATOCYTE SPECIFIC ANTIGEN (HSA), IMMUNOHISTOCHEMISTRY COMPREHENSIVE PANEL, Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, IMMUNOHISTOCHEMISTRY, NEUROENDOCRINE TUMOR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: DOUBLE NEGATIVE T CELLS (DNT), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD16 + 56, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD34 (STEM CELL) ENUMERATION, IMMUNOGLOBULIN IgG SYNTHESIS INDEX & RATE, IMMUNOHISTOCHEMISTRY, PD-L1 SP263 (VENTANA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD103, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD10 (CALLA), IMMUNOHISTOCHEMISTRY, PDL1 SP142 (Ventana), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD117, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD11c, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD123, IMMUNOHISTOCHEMISTRY, BLADDER VS PROSTATE CARCINOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD13, IMMUNOHISTOCHEMISTRY, GERM CELL TUMOUR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD138, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD14, IMMUNOHISTOCHEMISTRY, PITUITARY ADENOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD15, IMMUNOHISTOCHEMISTRY, PROSTATE BENIGN VS MALIGNANT PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD19, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD1a, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD20, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD22, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD23, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD25, IMMUNOHISTOCHEMISTRY CARBONIC ANHYDRASE-9 (CA-9), IMMUNOHISTOCHEMISTRY, THYROID CARCINOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD33, IMMUNOHISTOCHEMISTRY, THYROID STIMULATING HORMONE (TSH), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD34, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD36, IMMUNOHISTOCHEMISTRY, SINGLE MARKER WITHOUT IINTERPRETATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD38, IMMUNOHISTOCHEMISTRY, ANY 5 MARKERS WITHOUT INTERPRETATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD41a, IMMUNOHISTOCHEMISTRY, ANY 3 MARKERS WITHOUT INTERPRETATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD45, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD61, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD64, IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 1, IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD79a, IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD79b, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD MPO, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, FMC-7, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, GLYCOPHORIN, IMMUNOHISTOCHEMISTRY, GLUTAMINE SYNTHETASE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, HLA DR, IMMUNOHISTOCHEMISTRY GLYCOPHORIN A (GPA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgG HEAVY CHAIN CYTOPLASMIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgG HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgM HEAVY CHAIN CYTOPLASMIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgM HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, KAPPA & LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LYMPHOMA DIAGNOSTIC PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, ZAP-70, IMMUNOHISTOCHEMISTRY, ESTROGEN RECEPTOR (ER), IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2, IMMUNOHISTOCHEMISTRY, 34-BETA E12 / HMW-CK, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD49d, INSULIN FASTING (F) & POST PRANDIAL (PP) PANEL, IMMUNOHISTOCHEMISTRY, ACTIN (SMOOTH MUSCLE ACTIN), JAK 2 V617F REFLEX TO JAK 2 EXON 12 MUTATION DETECTION, JAPANESE ENCEPHALITIS VIRUS (JEV) DETECTION PCR, JAK 2 V617F, CALR & MPL MUTATION DETECTION PROFILE, KETONE BODY (BETA HYDROXYBUTYRATE), SERUM, KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL, LEUKEMIA GENETIC PROFILE - ANY 6 MARKERS PCR QUALITATIVE, Lp-PLA2 (LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2) ACTIVITY, LYME DISEASE (BORRELIA BURGDORFERI) ANTIBODIES IgG & IgM, LYME DISEASE (BORRELIA BURGDORFERI) DNA QUALITATIVE REAL TIME PCR, LIPOPROTEIN FRACTIONATION, ULTRACENTRIFUGATION, LYME DISEASE (BORRELIA BURGDORFERI) IgG & IgM IMMUNOBLOT, LYME DISEASE (BORRELIA BURGDORFERI) IgG IMMUNOBLOT, LEGIONELLA PNEUMOPHILA IgG ANTIBODY, SERUM, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IFA, LEIGH SYNDROME MITOCHONDRIAL MUTATION DETECTION, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS IFA, LEBER'S HEREDITARY OPTIC NEUROPATHY (LHON) MITOCHONDRIAL MUTATION DETECTION, LEUCOCYTE ADHESION DEFICIENCY (LAD I & II), LEISHMANIA (KALA AZAR) rK-39 ANTIBODY, SERUM, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL, MYELOPEROXIDASE (MPO) STAIN, BLOOD / BONE MARROW, MEASLES (RUBEOLA) ANTIBODIES PANEL IgG & IgM, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL, MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED PROFILE, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR B-CLL, MYELOPROLIFERATIVE NEOPLASIA WITH EOSINOPHILIA, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR MULTIPLE MYELOMA, MEDULLARY THYROID CARCINOMA MUTATION DETECTION, MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS; VAN DER KNAAP AND NALBAND MLC GENE HOTSPOT MUTATION, MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) MUTATION DETECTION, MYOSITIS PROFILE EXTENDED IgG : 16 ANTIGENS, MITOCHONDRIAL MUTATION DETECTION COMPREHENSIVE PANEL, MIXING STUDIES - APTT WITH PROTHROMBIN TIME STUDIES, MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES) MUTATION DETECTION, MMC (MATERNAL MYOPATHY WITH CARDIOMYOPATHY) MUTATION DETECTION, MYELIN ASSOCIATED GLYCOPROTEIN (MAG) IgM, METACHROMATIC LEUCODYSTROPHY QUANTITATIVE, BLOOD, MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) PANEL, MPL (MYELOPROLIFERATIVE LEUKEMIA) GENE MUTATION, MTHFR (METHYLENE TETRAHYDROFOLATE REDUCTASE) GENE MUTATION, QUALITATIVE PCR, MYELIN ASSOCIATED GLYCOPROTEIN- SULFATED GLUCURONIC PARAGLOBOSIDE AUTOANTIBODY (MAG-SGPG) IgM, METANEPHRINES FRACTIONATED, 24 HOUR URINE, MUCOPOLYSACCHARIDOSIS (MPS) SCREEN, URINE, MUCOPOLYSACCHARIDOSIS (MPS) TYPE 1 (HURLER) QUANTITATIVE, BLOOD, METANEPHRINES FRACTIONATED, RANDOM URINE, MUCOPOLYSACCHARIDOSIS (MPS) TYPE VI (MAROTEAUX LAMY) QUANTITATIVE, BLOOD, MUCOPOLYSACCHARIDOSIS (MPS) TYPING, 24 HOUR URINE, MALARIA PARASITE / BLOOD PARASITE IDENTIFICATION, MICM (MATERNALLY INHERITED CARDIOMYOPATHY) MUTATION DETECTION, MICROALBUMIN/ALBUMIN, 1ST MORNING / RANDOM URINE, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT, MICROALBUMIN/ALBUMIN CREATININE RATIO, URINE, MATERNAL SERUM SCREEN 2: ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA (MBFD)/NIPT CHROMOSOME 21, MYCOBACTERIUM TUBERCULOSIS PCR; MYCOSURE; TB PCR, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT WITH MICRODELETIONS, MYCOBACTERIUM TUBERCULOSIS rRNA DETECTION, TMA, MYCOPLASMA PNEUMONIAE IgG & IgM ANTIBODIES PANEL, SERUM, MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION; MCHC, MITOCHONDRIAL ANTIBODY (AMA) IFA IN DILUTIONS, Nx GEN SEQUENCING: AMYOTROPHIC LATERAL SCLEROSIS, Nx GEN SEQUENCING: COMPREHENSIVE EPILEPSY, Nx GEN SEQUENCING: FAMILIAL HEMIPLEGIC MIGRAINE, NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) FIBROSIS SCORE, Nx GEN SEQUENCING: HEREDITARY RETINOBLASTOMA, Nx GEN SEQUENCING: LEBER CONGENITAL AMAUROSIS, Nx GEN SEQUENCING: MEGALOENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS, Nx GEN SEQUENCING: MICROPHTHALMIA / ANOPHTHALMIA / COLOBOMA SPECTRUM, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ULTRA, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE, NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ADVANCED, NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE), NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR, NTx (COLLAGEN CROSS-LINKED N- TELOPEPTIDE), URINE, Nx GEN SEQUENCING: BETHLEM MYOPATHY, MYOFIBRILLAR MYOPATHY & ULLRICH MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: CHARCOT-MARIE-TOOTH DISEASE & SENSORY NEUROPATHIES, Nx GEN CLINICAL EXOME SEQUENCING, ILLUMINA, Nx GEN SEQUENCING: DRAVET'S SYNDROME & EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY, Nx GEN CLINICAL EXOME SEQUENCING, THERMOFISHER, Nx GEN SEQUENCING: DUCHENNE & BECKER MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: MATURITY ONSET DIABETES OF YOUNG (MODY), Nx GEN SEQUENCING: AICARDI-GOUTIERES SYNDROME, Nx Gen Sequencing:Tuberous sclerosis complex, Nx GEN WHOLE EXOME SEQUENCING, THERMOFISHER, NGAL (NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN), URINE, ONCOPRO HEREDITARY CANCER RISK PANEL (Screens 200 Genes), ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL, ONCOMINE CHRONIC MYELOID LEUKAEMIA (CML) PANEL, OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST, ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL, ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) PANEL, ONCOMINE MYELODYSPLASTIC SYNDROME(MDS) PANEL, ONCOMINE MYELOPROLIFERATIVE NEOPLASM (MPN) PANEL, ONCOPRO COMPREHENSIVE CANCER PANEL: 161 GENES, OPPORTUNISTIC ENTERIC PARASITE SCREEN, STOOL, ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS, P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE), TOTAL, PIIINP (PROCOLLAGEN TYPE III AMINO TERMINAL PROPEPTIDE), PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1), PAN FUNGAL DETECTION AND IDENTIFICTION, PCR, PLASMINOGEN ACTIVATOR INHIBITOR-1/SERPINE-1, 4G/5G GENOTYPING, PAPP-A (PREGNANCY ASSOCIATED PLASMA PROTEIN-A), PARIETAL CELL ANTIBODY, IFA IN DILUTIONS, PTHrP; PARATHYROID HORMONE RELATED PROTEIN, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE PCR, PURKINJE CELL (Yo) ANTIBODY SCREEN, WITH REFLEX TO TITER AND WESTERN BLOT, CSF, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUALITATIVE PCR, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) CONFIRMATORY TEST, PURKINJE CELL CYTOPLASMIC ANTIBODY TYPE Tr (DNER), PARTIAL THROMBOPLASTIN TIME ACTIVATED; PTT; APTT, PARVOVIRUS B19 ANTIBODIES PANEL IgG & IgM, PORPHOBILINOGEN (PBG) QUANTITATIVE, 24 HOUR URINE, PCNA (PROLIFERATING CELL NUCLEAR ANTIGEN) ANTIBODY, PCOD (POLYCYSTIC OVARIAN DISEASE) COMPREHENSIVE PANEL, PORPHYRINS TOTAL QUALITATIVE, RANDOM URINE, PORPHYRINS TOTAL QUANTITATIVE, 24- HOUR URINE, PRADER-WILLI SYNDROME MUTATION DETECTION METHYLATION SPECIFIC PCR, PRE-ECLAMPSIA PREDICTOR (sFLT-1:PIGF RATIO) PANEL, PHOSPHATIDYLSERINE ANTIBODIES PANEL IgG & IgM, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE, PROTEIN ELECTROPHORESIS & IMMUNOTYPING, SERUM, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUANTITATIVE, PHOSPHOLIPID SYNDROME PANEL WITH BETA 2 GLYCOPROTEIN 1, IHR, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, Q FEVER (COXIELLA BURNETTI) ANTIBODIES IgG & IgM, ROCKY MOUNTAIN SPOTTED FEVER ANTIBODIES, ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM, RHEUMATOID AUTOIMMUNE COMPREHENSIVE PANEL, RUBELLA (GERMAN MEASLES) ANTIBODIES PANEL IgG & IgM, RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIGEN, SALMONELLA TYPHI AND SALMONELLA PARATYPHI A ANTIGEN DETECTION, SOLUBLE TRANSFERRIN RECEPTOR (sTfR), SERUM, SARS-CoV-2 (COVID-19) NEUTRALIZING ANTIBODY, SARS-COV-2 (COVID-19) RESPIRATORY COMPREHENSIVE PANEL, Swasthfit Heart Check - Advance Health Checkup, SCA-11 (SPINOCEREBELLAR ATAXIA): TTBK2 GENE MUTATION, SPERM DNA FRAGMENTATION FLUORESCENT MICROSCOPY, SCA-12 (SPINOCEREBELLAR ATAXIA): PPP2R2B GENE MUTATION, SCA-17 (SPINOCEREBELLAR ATAXIA): TBP GENE MUTATION, SCA-1 (SPINOCEREBELLAR ATAXIA): ATXN1 GENE MUTATION, SCA-2 (SPINOCEREBELLAR ATAXIA): ATXN2 GENE MUTATION, SPINAL MUSCULAR ATROPHY (SMA) CARRIER DETECTION, Swasthfit Pro 3 (With Free Doctor Consultation), SCA-3 (SPINOCEREBELLAR ATAXIA): ATXN3 GENE MUTATION, SPINAL MUSCULAR ATROPHY (SMA) MUTATION DETECTION, SCA-5 (SPINOCEREBELLAR ATAXIA): SPTBN2 GENE MUTATION, SCA-6 (SPINOCEREBELLAR ATAXIA): CACNA1A GENE MUTATION, SCA (SPINOCEREBELLAR ATAXIA) PROFILE: ANY 4 MARKERS, SCA-7 (SPINOCEREBELLAR ATAXIA): ATXN7 GENE MUTATION, SCA-23 (SPINOCEREBELLAR ATAXIA): PDYN GENE MUTATION, SCA-8 (SPINOCEREBELLAR ATAXIA): ATXN8OS & ATXN8 GENE MUTATION, SCA-14 (SPINOCEREBELLAR ATAXIA): PRKCG GENE MUTATION, Swasthfit Total - Heart Check - Full Body Checkup, SCA (SPINOCEREBELLAR ATAXIA): COMPREHENSIVE PROFILE, Swasthfit Total - Iron Check - Full Body Checkup, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, RAPID ASSAY, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, EIA, STEROID PANEL: 21- HYDROXYLASE DEFICIENCY, Swasthfit Advance Health Checkup - Full Body Checkup, STEROID PANEL FOR CONGENITAL ADRENAL HYPERPLASIA (CAH), STEROID PANEL FOR PCOS / NON-CLASSICAL CAH DIFFERENTIATION, STEROID/ANDROGEN PROFILE FOR POLYCYSTIC OVARY SYNDROME (PCOS), STOOL EXAMINATION HANGING DROP PREPARATION, STOOL EXAMINATION pH & REDUCING SUBSTANCES, SICKLE CELL ANEMIA TRIO PRENATAL MUTATION DETECTION, Swasthfit Tax Saver Basic Health Checkup - Full Body Checkup, STREPTOCOCCUS GROUP B ANTIGEN DETECTION, Swasthfit Tax Saver Advance Health Checkup - Full Body Checkup, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA IN DILUTIONS, SARS-CoV-2 (COVID-19) QUALITATIVE REAL TIME RT-PCR, SMOOTH MUSCLE ANTIBODY (ASMA) IFA IN DILUTIONS, SCA (SPINOCEREBELLAR ATAXIA): EXTENDED PROFILE, TPHA; TREPONEMA PALLIDUM HEMAGGLUTINATION, TPMT (THIOPURINE METHYL TRANSFERASE) GENOTYPING, TB GOLD PLUS INTERFERON GAMMA RELEASE ASSAY (IGRA), TBII; THYROTROPIN - BINDING INHIBITORY IMMUNOGLOBULIN, TB LAMP (LOOP MEDIATED ISOTHERMA AMPLIFICATION) QUALITATIVE DNA PCR, MYCOBACTERIUM TUBERCULOSIS COMPLEX, TB PLATINUM INTERFERON GAMMA RELEASE ASSAY (IGRA), TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgG, TESTOSTERONE FREE & SEX HORMONE BINDING GLOBULIN, TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE), TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, CORD BLOOD, TSI; THYROID STIMULATING IMMUNOGLOBULIN, THALASSEMIA ALPHA TRIO PRENATAL MUTATION DETECTION, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgA, THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC, THALASSEMIA BETA TRIO PRENATAL MUTATION DETECTION, TOTAL WBC COUNT & DIFFERENTAL COUNT & ESR, TYPHUS FEVER (RICKETTSIA) ANTIBODIES IgG & IgM, TB GOLD INTERFERON GAMMA RELEASE ASSAY (IGRA), t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE, t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE, t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE, t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1) PCR QUALITATIVE, t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE, URINE EXAMINATION ROUTINE; URINE R/E AUTOMATED, UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE 'TA' REPEATS) DETECTION, VITAMIN B1 (THIAMINE PYROPHOSPHATE), BLOOD, VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) SCREENING, VITAMIN B12 BINDING CAPACITY UNSATURATED; TRANSCOBALAMIN, VARICELLA ZOSTER VIRUS (VZV) QUALITATIVE PCR, VMA (VANILLYL MANDELIC ACID), 24 HOUR URINE, VMA (VANILLYL MANDELIC ACID), RANDOM URINE, VON WILLEBRAND FACTOR COLLAGEN BINDING ACTIVITY (vWF:CB), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, SERUM, VON WILLEBRAND FACTOR RISTOCETIN COFACTOR ACTIVITY (vWF:RCo), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, CSF, VARICELLA ZOSTER VIRUS (VZV) ANTIBODIES PANEL IgG & IgM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgM, von WILLEBRAND FACTOR ANTIGEN; vWF Ag, WILSON DISEASE ATP7 B GENE MUTATION DETECTION, XPERT XPRESS SARS-CoV-2 (COVID-19) QUALITATIVE, Y-CHROMOSOME MICRODELETION DETECTION , PCR, YEAST (CANDIDA SPECIES) SUSCEPTIBILITY TESTING.
Disadvantages Of A Wet Wing, Bob's Burgers Jocelyn Quotes, Michael Kitces Podcast, Jamie Apocalypse Costume Male, Vintage Gibson Firebird For Sale, Sam Kuffel Engaged, Bruno Mars Net Worth,